HUT77361A - 1,2-Etándiol-származékot vagy sóját tartalmazó gyógyszerkészítmény ideg növekedési faktor (NFG) aktivitás potenciálására - Google Patents
1,2-Etándiol-származékot vagy sóját tartalmazó gyógyszerkészítmény ideg növekedési faktor (NFG) aktivitás potenciálásáraInfo
- Publication number
- HUT77361A HUT77361A HU9701903A HU9701903A HUT77361A HU T77361 A HUT77361 A HU T77361A HU 9701903 A HU9701903 A HU 9701903A HU 9701903 A HU9701903 A HU 9701903A HU T77361 A HUT77361 A HU T77361A
- Authority
- HU
- Hungary
- Prior art keywords
- salt
- pharmaceutical composition
- growth factor
- nerve growth
- factor containing
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D307/78—Benzo [b] furans; Hydrogenated benzo [b] furans
- C07D307/79—Benzo [b] furans; Hydrogenated benzo [b] furans with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C217/00—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton
- C07C217/02—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton
- C07C217/04—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
- C07C217/06—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one etherified hydroxy group and one amino group bound to the carbon skeleton, which is not further substituted
- C07C217/08—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one etherified hydroxy group and one amino group bound to the carbon skeleton, which is not further substituted the oxygen atom of the etherified hydroxy group being further bound to an acyclic carbon atom
- C07C217/10—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one etherified hydroxy group and one amino group bound to the carbon skeleton, which is not further substituted the oxygen atom of the etherified hydroxy group being further bound to an acyclic carbon atom to an acyclic carbon atom of a hydrocarbon radical containing six-membered aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/50—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
- C07D333/52—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes
- C07D333/54—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D453/00—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids
- C07D453/02—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids containing not further condensed quinuclidine ring systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/08—Bridged systems
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP6284273A JPH08268883A (ja) | 1994-10-25 | 1994-10-25 | １−フェニル−１，２−エタンジオール誘導体またはそ の塩を含有する神経成長因子の作用増強剤 |
| JP28427294 | 1994-10-25 | ||
| PCT/JP1995/002162 WO1996012717A1 (fr) | 1994-10-25 | 1995-10-20 | Potentialisateur de l'activite du facteur de croissance nerveuse contenant un derive de 1,2-ethanediol ou un sel de celui-ci |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| HUT77361A true HUT77361A (hu) | 1998-03-30 |
| HU226980B1 HU226980B1 (en) | 2010-04-28 |
Family
ID=26555404
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HU9701903A HU226980B1 (en) | 1994-10-25 | 1995-10-20 | Use of 1,2-ethanediol derivatives or salts thereof for the preparation of pharmaceutical compositions having nerve growth factor (nfg) potentiator activity |
Country Status (16)
| Country | Link |
|---|---|
| US (6) | US5807887A (hu) |
| EP (3) | EP0790246B1 (hu) |
| JP (1) | JP3218247B2 (hu) |
| KR (1) | KR100447738B1 (hu) |
| AU (1) | AU700561B2 (hu) |
| CA (1) | CA2202032C (hu) |
| CZ (1) | CZ293528B6 (hu) |
| DE (2) | DE69531877T2 (hu) |
| DK (2) | DK1020427T3 (hu) |
| ES (2) | ES2208156T3 (hu) |
| HU (1) | HU226980B1 (hu) |
| NZ (1) | NZ294328A (hu) |
| PL (2) | PL187004B1 (hu) |
| RO (1) | RO119196B1 (hu) |
| TW (1) | TW341570B (hu) |
| WO (1) | WO1996012717A1 (hu) |
Families Citing this family (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR100447738B1 (ko) * | 1994-10-25 | 2005-09-20 | 도야마 가가쿠 고교 가부시키가이샤 | 1,2-에탄디올유도체또는그의염을함유한의약조성물 |
| ZA973394B (en) * | 1996-04-22 | 1997-11-20 | Toyama Chemical Co Ltd | Plaster containing 1,2-ethanediol derivative or a salt thereof. |
| AU1506499A (en) * | 1997-12-12 | 1999-07-05 | Toyama Chemical Co. Ltd. | Alkyl ether derivatives or salts thereof and calcium antagonists containing the same |
| JP4549452B2 (ja) * | 1997-12-12 | 2010-09-22 | 富山化学工業株式会社 | アルキルエーテル誘導体またはその塩並びにそれらを含有するカルシウム拮抗剤 |
| DK1186594T3 (da) * | 1999-06-11 | 2009-09-14 | Toyama Chemical Co Ltd | N-alkoxylkyl-N,N-dialkylamin-derivater eller salte deraf og midler mod neurodegenerative sygdomme, som indeholder disse |
| AU9235101A (en) * | 2000-10-10 | 2002-04-22 | Toyama Chemical Co Ltd | Remedies for retinal nerve diseases containing 1,2-ethanediol derivatives or salts thereof |
| HU230407B1 (hu) | 2001-10-19 | 2016-04-28 | Toyama Chemical Co., Ltd. | Alkil-éter-származékok és sóik |
| MXPA04012534A (es) | 2002-06-14 | 2005-04-19 | Toyama Chemical Co Ltd | Composicion farmaceutica para mejorar la funcion cerebral y metodo para mejorar la funcion cerebral. |
| EP2248899B8 (en) | 2003-03-19 | 2015-07-15 | Biogen MA Inc. | NOGO receptor binding protein |
| US8486893B2 (en) | 2004-06-24 | 2013-07-16 | Biogen Idec Ma Inc. | Treatment of conditions involving demyelination |
| EP1904104B1 (en) | 2005-07-08 | 2013-09-11 | Biogen Idec MA Inc. | Sp35 antibodies and uses thereof |
| JP2009544703A (ja) | 2006-07-24 | 2009-12-17 | バイオジェン・アイデック・エムエイ・インコーポレイテッド | Ｓｐ３５またはＴｒｋＡアンタゴニストの投与により髄鞘形成、ニューロンの生存および希乏突起膠細胞の分化を促進するための方法 |
| JP5674469B2 (ja) * | 2007-10-11 | 2015-02-25 | バイオジェン・アイデック・エムエイ・インコーポレイテッド | ＬＩＮＧＯ−１アンタゴニストおよびＴｒｋＢアゴニストの投与を介して圧力誘導性の視神経障害を処置し、神経変性を防ぎ、ニューロン細胞の生存を促進する方法 |
| US20110123553A1 (en) * | 2007-11-08 | 2011-05-26 | Biogen Idec Ma Inc. | Use of LINGO-4 Antagonists in the Treatment of Conditions Involving Demyelination |
| AU2009269099B2 (en) | 2008-07-09 | 2016-03-10 | Biogen Ma Inc. | Compositions comprising antibodies to LINGO or fragments thereof |
| NZ702178A (en) | 2012-05-14 | 2017-01-27 | Biogen Ma Inc | Lingo-2 antagonists for treatment of conditions involving motor neurons |
| EP3242893A1 (en) | 2015-01-08 | 2017-11-15 | Biogen MA Inc. | Lingo-1 antagonists and uses for treatment of demyelinating disorders |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3894058A (en) * | 1974-05-17 | 1975-07-08 | Hoechst Co American | Tetrahydrobenzofuranylphenoxypropylamines |
| US5254595A (en) * | 1988-12-23 | 1993-10-19 | Elf Sanofi | Aryloxypropanolaminotetralins, a process for their preparation and pharmaceutical compositions containing them |
| NZ232493A (en) * | 1989-02-14 | 1992-06-25 | Toyama Chemical Co Ltd | Aryl- or heterocyclyl-substituted 1,2-ethanediol derivatives and pharmaceutical compositions |
| US5280032A (en) * | 1989-02-14 | 1994-01-18 | Toyama Chemical Co., Ltd. | 1,2-ethanediol derivative and salt thereof, process for producing the same, and cerebral function-improving agent comprising the same |
| JP3044055B2 (ja) * | 1990-08-09 | 2000-05-22 | 富山化学工業株式会社 | １，２―エタンジオール誘導体およびその塩 |
| JPH05230103A (ja) * | 1992-02-18 | 1993-09-07 | Taisho Pharmaceut Co Ltd | ガングリオシド化合物 |
| KR100447738B1 (ko) * | 1994-10-25 | 2005-09-20 | 도야마 가가쿠 고교 가부시키가이샤 | 1,2-에탄디올유도체또는그의염을함유한의약조성물 |
-
1995
- 1995-10-20 KR KR1019970702690A patent/KR100447738B1/ko not_active IP Right Cessation
- 1995-10-20 ES ES00100580T patent/ES2208156T3/es not_active Expired - Lifetime
- 1995-10-20 CA CA002202032A patent/CA2202032C/en not_active Expired - Fee Related
- 1995-10-20 JP JP51377896A patent/JP3218247B2/ja not_active Expired - Fee Related
- 1995-10-20 EP EP95934859A patent/EP0790246B1/en not_active Expired - Lifetime
- 1995-10-20 DK DK00100580T patent/DK1020427T3/da active
- 1995-10-20 WO PCT/JP1995/002162 patent/WO1996012717A1/ja active IP Right Grant
- 1995-10-20 NZ NZ294328A patent/NZ294328A/en not_active IP Right Cessation
- 1995-10-20 CZ CZ19971249A patent/CZ293528B6/cs not_active IP Right Cessation
- 1995-10-20 EP EP02004782A patent/EP1223169A1/en not_active Withdrawn
- 1995-10-20 RO RO97-00775A patent/RO119196B1/ro unknown
- 1995-10-20 PL PL95319940A patent/PL187004B1/pl not_active IP Right Cessation
- 1995-10-20 PL PL95359927A patent/PL187490B1/pl not_active IP Right Cessation
- 1995-10-20 US US08/809,407 patent/US5807887A/en not_active Expired - Fee Related
- 1995-10-20 DE DE69531877T patent/DE69531877T2/de not_active Expired - Fee Related
- 1995-10-20 DE DE69525063T patent/DE69525063T2/de not_active Expired - Fee Related
- 1995-10-20 DK DK95934859T patent/DK0790246T3/da active
- 1995-10-20 EP EP00100580A patent/EP1020427B1/en not_active Expired - Lifetime
- 1995-10-20 HU HU9701903A patent/HU226980B1/hu not_active IP Right Cessation
- 1995-10-20 ES ES95934859T patent/ES2171559T3/es not_active Expired - Lifetime
- 1995-10-20 AU AU37097/95A patent/AU700561B2/en not_active Ceased
- 1995-10-23 TW TW084111184A patent/TW341570B/zh active
-
1997
- 1997-12-31 US US09/001,651 patent/US5932620A/en not_active Expired - Fee Related
- 1997-12-31 US US09/001,656 patent/US5922721A/en not_active Expired - Fee Related
- 1997-12-31 US US09/001,650 patent/US5968935A/en not_active Expired - Fee Related
-
1999
- 1999-02-18 US US09/252,199 patent/US6034119A/en not_active Expired - Fee Related
- 1999-03-09 US US09/264,713 patent/US6103754A/en not_active Expired - Fee Related
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HUT77361A (hu) | 1,2-Etándiol-származékot vagy sóját tartalmazó gyógyszerkészítmény ideg növekedési faktor (NFG) aktivitás potenciálására | |
| AU691361B2 (en) | Novel 2,3-diketopiperazine derivative or salt thereof | |
| IL115039A (en) | Spiroazabicyclic compounds, their preparation and pharmaceutical compositions containing them | |
| SI0807111T1 (en) | Substituted heterocyclic compounds, preparation method therefor and pharmaceutical compositions containing same | |
| HUP9801157A3 (en) | Composition and methods for using 1,2,3-thiadiazole derivatives for agricultural and horticultural disease control | |
| HUP9901159A3 (en) | Substituted benzylaminopiperidine derivatives and use thereof, pharmaceutical compositions containing these compounds | |
| AU3091489A (en) | Piperazine derivative or its salt, process for producing the same and pharmaceutical composition comprising the same as active ingredient | |
| HUP9901684A3 (en) | Lipoprotein (a) lowering activity aminophosphonate derivatives, preparation and use thereof, pharmaceutical compositions containing these compounds | |
| IL118426A0 (en) | Pharmaceutical composition containing 1,3-bis-triazolyl-2- propanol derivative | |
| HUP9701194A3 (en) | 4-hydroxy-piperidine derivatives, preparation and use thereof, pharmaceutical compositions containing these compounds | |
| HU9502918D0 (en) | Pharmaceutical composition of antihypertriglyceridemic activity | |
| IL134536A0 (en) | Compounds possessing neuronal activity and pharmaceutical compositions containing the same | |
| IL112443A0 (en) | Heterocyclic compounds, their preparation and pharmaceutical compositions containing them | |
| HUP9602266A3 (en) | Quickly decomposing pharmaceutical composition containing tramadol or a tramadol salt | |
| IL84845A0 (en) | Pharmaceutical compositions comprising a certain carbazolone derivative or a salt thereof | |
| GB9410898D0 (en) | Pharmaceutical compositions having analgesic activity | |
| HUP9902166A3 (en) | Substituted benzamide derivatives having anticonvulsant activity, preparation and use thereof, pharmaceutical compositions containing these compounds | |
| IL108800A0 (en) | Heterocyclic compounds, their preparation and pharmaceutical compositions containing them | |
| HUP9802741A3 (en) | Pharmaceutical composition containing tiagabine or its salt and the process for its preparation | |
| HUP0001101A3 (en) | Insecticidal compositions containing 3-cyano-8-azabicyclo[3.2.1]octane derivative as activity-enhancing compound and use thereof | |
| IL115843A0 (en) | Pharmaceutical composition containing cisapride-(l)-tartrate | |
| IL106385A0 (en) | Heterocyclic compounds,their preparation and pharmaceutical compositions containing them | |
| IL106041A0 (en) | Heterocyclic compounds,their preparation and pharmaceutical compositions containing them | |
| HUP9902149A3 (en) | 1-methylcarbapenem derivatives with antibacterial activity, use thereof, pharmaceutical compositions containing these compounds | |
| IL109527A0 (en) | Substituted piperazines, their preparation and pharmaceutical compostions containing them |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MM4A | Lapse of definitive patent protection due to non-payment of fees |